BindingDB logo
myBDB logout

BDBM145610 US8952169, 413

SMILES: CC1CCC(COc2cc(F)c(cc2C2CC2)C(=O)NS(=O)(=O)C2CC2)CC1

InChI Key: InChIKey=YGEKNWWTPROKJF-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 145610   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM145610
PNG
(US8952169, 413)
Show SMILES CC1CCC(COc2cc(F)c(cc2C2CC2)C(=O)NS(=O)(=O)C2CC2)CC1 |w:5.4,1.0,(-8.77,-3.18,;-7.44,-2.41,;-7.44,-.87,;-6.1,-.1,;-4.77,-.87,;-3.44,-.1,;-2.1,-.87,;-.77,-.1,;-.77,1.44,;.56,2.21,;.56,3.75,;1.9,1.44,;1.9,-.1,;.56,-.87,;.56,-2.41,;-.21,-3.75,;1.33,-3.75,;3.23,2.21,;3.23,3.75,;4.56,1.44,;5.9,2.21,;5.13,3.54,;6.67,3.54,;7.23,1.44,;8,.1,;8.77,1.44,;-4.77,-2.41,;-6.1,-3.18,)|
Show InChI InChI=1S/C21H28FNO4S/c1-13-2-4-14(5-3-13)12-27-20-11-19(22)18(10-17(20)15-6-7-15)21(24)23-28(25,26)16-8-9-16/h10-11,13-16H,2-9,12H2,1H3,(H,23,24)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 3n/an/an/an/an/a37



Xenon Pharmaceuticals Inc.; Genentech, Inc.

US Patent


Assay Description
Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and all...


US Patent US8952169 (2015)


BindingDB Entry DOI: 10.7270/Q2M04445
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM145610
PNG
(US8952169, 413)
Show SMILES CC1CCC(COc2cc(F)c(cc2C2CC2)C(=O)NS(=O)(=O)C2CC2)CC1 |w:5.4,1.0,(-8.77,-3.18,;-7.44,-2.41,;-7.44,-.87,;-6.1,-.1,;-4.77,-.87,;-3.44,-.1,;-2.1,-.87,;-.77,-.1,;-.77,1.44,;.56,2.21,;.56,3.75,;1.9,1.44,;1.9,-.1,;.56,-.87,;.56,-2.41,;-.21,-3.75,;1.33,-3.75,;3.23,2.21,;3.23,3.75,;4.56,1.44,;5.9,2.21,;5.13,3.54,;6.67,3.54,;7.23,1.44,;8,.1,;8.77,1.44,;-4.77,-2.41,;-6.1,-3.18,)|
Show InChI InChI=1S/C21H28FNO4S/c1-13-2-4-14(5-3-13)12-27-20-11-19(22)18(10-17(20)15-6-7-15)21(24)23-28(25,26)16-8-9-16/h10-11,13-16H,2-9,12H2,1H3,(H,23,24)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 4n/an/an/an/a7.425



Xenon Pharmaceuticals Inc.; Genentech, Inc.

US Patent


Assay Description
Radioligand Binding Studies: Saturation experiments. A representative compound of formula (I) was tritiated. Three tritiums were incorporated in plac...


US Patent US8952169 (2015)


BindingDB Entry DOI: 10.7270/Q2M04445
More data for this
Ligand-Target Pair